NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, recently concluded an advanced MWA training session in New Orleans. This initiative reinforces the Company's commitment to accelerating the adoption of minimally invasive therapies through strategic physician education. The specialized training program was led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine. The program provided advanced trai

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary. Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead all U.S. operations, including sales, marketing, and market development, as Baird Medical

NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official launch into the Egyptian market with the successful completion of its first procedure at the prestigious Ain Shams Specialized Hospital. The landmark case involved a bone ablation performed by Dr. Amr Mahmoud. The patient, a 30-year-old male suffering from left thigh pain, was found to have a 1 x 1.5 cm bone lesion. The MWA procedure was completed safely and effectively, achieving fu

NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York. Dr. Kazeem, a highly experienced endocrinologist with over 30 years of clinical practice, has performed nine MWA procedures in recent months. The procedures focused on treating patients with large thyroid nodules, offering a non-surgical alternative. The clinic reported that

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of its first MWA procedure in Bangladesh. The landmark treatment was performed at USB Hospital in Uttara, Dhaka, marking a significant step forward in the availability of cutting-edge, non-surgical cancer therapies in the region. The procedure was led by Dr. Mofazzal Sharif Rasel, a distinguished interventional radiologist, and his expert medical team. The patient, a 65

In the news release, Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia, issued 21-Oct-2025 by BDMD over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Jiangsu Provincial Hospital, alongside HCTM's B&E Surgeons Dr. Adi Syazni and Prof. Shahrun Niza, the program featured a rigorous curriculum encompassing theoretical lectures, complex case discussions, and practical training sessions using both mannequins and live patient cases." rather than "...endocrinologist at Nanjing University of Traditional Chines

NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia. The immersive two-day workshop, held from October 1–2, 2025, brought together leading surgeons and endocrinologists for intensive, hands-on training. Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Nanjing Un

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share

NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its system was successfully used in two minimally invasive procedures at UCSF Health. Esteemed interventional radiologist Dr. Alexander Lam performed the procedures, treating large, symptomatic thyroid nodules that would typically require surgery. The cases involved two patients with benign nodules measuring 5.0 cm and 6.5 cm. The non-surgical ablations were complete

NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University. The study abstract, presented at the recent American Thyroid Association (ATA) Annual Meeting, concludes that management strategies incorporating transcutaneous thyroid nodule ablation (TNA) can lead to lower healthcare costs and improved patient quality of life.

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NT 20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

S-8 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary. Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead all U.S. operations, including sales, marketing, and market development, as Baird Medical

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share